Likewise, GLP-1 analogues have demonstrated favorable actions in rodent models of peripheral neuropathy [22] as well as Alzheimer's disease (AD) [17], [23]. The gene discussed is GLP1R; the disease is early-onset autosomal dominant Alzheimer disease.